TREATMENT OF METABOLICLY ASSOCIATED FATTY LIVER HEPATOSIS IN THE YOUNG POPULATION

Authors

  • Maxamatov Umidjon Shoirjonovich, Qosimov Zafarbek Odiljon ugli, Jumaev Akbar Khamidovich, Alimova Nigina Pulatovna, Idiyev Oybek Elmurodovich, Khaydarova Nasiba Adkhamovna Author

Abstract

 One of the main pathogenetic signs of metabolic syndrome is abdominal obesity, which underlies the development of diseases associated with metabolic disorders - carbohydrate metabolism disorders and atherogenic dyslipidemia. The presence of abdominal obesity and metabolic disorders contributes to the development of combined damage to the liver (non-alcoholic fatty liver disease - NAFLD), biliary tract, heart, and pancreas (with the development of steatosis).

Downloads

Published

2024-10-25

Issue

Vol. 6 No. 2 (2024)

Section

Articles

How to Cite

TREATMENT OF METABOLICLY ASSOCIATED FATTY LIVER HEPATOSIS IN THE YOUNG POPULATION. (2024). CAHIERS MAGELLANES-NS, 6(2), 6512-6515. https://magellanes.com/index.php/CMN/article/view/984